Targeted Immunotherapies for Cancers-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Targeted Immunotherapies for Cancers

Published:2023-12-19 Issue:1 Volume:16 Page:11
ISSN:2072-6694
Container-title:Cancers
language:en
Short-container-title:Cancers

Author:

Cheung Anthony¹²^ORCID,Chenoweth Alicia¹²

Affiliation:

1. Breast Cancer Now Research Unit, School of Cancer & Pharmaceutical Sciences, King’s College London, Guy’s Cancer Centre, London SE1 9RT, UK

2. St. John’s Institute of Dermatology, School of Basic & Medical Biosciences, King’s College London, Guy’s Hospital, London SE1 9RT, UK

Abstract

Advancements in immunotherapy have revolutionized cancer treatment in a broad variety of hematological and solid malignancies and rejuvenated the field of cancer immunology [...]

Publisher

MDPI AG

Subject

Cancer Research,Oncology

Link

https://www.mdpi.com/2072-6694/16/1/11/pdf

Reference14 articles.

1. Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck;Ferris;N. Engl. J. Med.,2016

2. Resistance Mechanisms to Immune-Checkpoint Blockade in Cancer: Tumor-Intrinsic and -Extrinsic Factors;Pitt;Immunity,2016

3. Cancer immunoediting and resistance to T cell-based immunotherapy;Teng;Nat. Rev. Clin. Oncol.,2019

4. Antibodies to watch in 2023;Kaplon;MAbs,2023

5. Pembrolizumab monotherapy for previously treated metastatic triple-negative breast cancer: Cohort A of the phase II KEYNOTE-086 study;Adams;Ann. Oncol.,2019

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP